Literature DB >> 7244660

The role of parmacologic manipulation in adrenal cortical scintigraphy.

M D Gross, T W Valk, D P Swanson, J H Thrall, R J Grekin, W H Beirewaltes.   

Abstract

Adrenal scintigraphy is a unique nuclear medicine procedure that provides noninvasive, functional information concerning the status of the adrenal cortex. The uptake of iodocholesterol, in addition to localizing adrenal cortical abnormalities, can be manipulate to focus on adrenal cortical dysfunction in either the aldosterone, cortisol, or androgenproducing portions of the adrenal cortex. The uptake of iodocholesterol correlates significantly with the abnormal secretion of cortisol in Cushing's syndrome, aldosterone in the model of adrenal zona glomerulosa function, and adrenal androgen secretion in hyperandorgenism. For these reasons, adrenal scintigraphy is an important diagnostic modality in the evaluation of adrenal cortical function.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7244660     DOI： 10.1016/s0001-2998(81)80042-6

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN： 0001-2998            Impact factor:   4.446


  10 in total

Review 1.  Contemporary adrenal scintigraphy.

Authors:  Milton D Gross; Anca Avram; Lorraine M Fig; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-25       Impact factor: 9.236

2.  Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.

Authors:  D Macfarlane; J Gonin; D Wieland; T Mangner; J Froelich; W Beierwaltes; B Shapiro
Journal:  Eur J Nucl Med       Date:  1996-02

3.  Scintigraphy of incidentally discovered bilateral adrenal masses.

Authors:  M D Gross; B Shapiro; I R Francis; R L Bree; M Korobkin; M K McLeod; N W Thompson; J A Sanfield
Journal:  Eur J Nucl Med       Date:  1995-04

Review 4.  Drug interactions with radiopharmaceuticals.

Authors:  S Hesslewood; E Leung
Journal:  Eur J Nucl Med       Date:  1994-04

5.  Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy.

Authors:  Ching-Chu Lu; Vin-Cent Wu; Kwan-Dun Wu; Kao-Lang Liu; Wei-Chou Lin; Mei-Fang Cheng; Kai-Yuan Tzen; Ruoh-Fang Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-14       Impact factor: 9.236

Review 6.  Adverse reactions and drug interactions with radiopharmaceuticals.

Authors:  C B Sampson
Journal:  Drug Saf       Date:  1993-04       Impact factor: 5.606

7.  NP-59 Adrenal Scintigraphy as an Imaging Biomarker to Predict KCNJ5 Mutation in Primary Aldosteronism Patients.

Authors:  Ching-Chu Lu; Ruoh-Fang Yen; Kang-Yung Peng; Jei-Yie Huang; Kwan-Dun Wu; Jeff S Chueh; Wan-Yu Lin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-28       Impact factor: 5.555

8.  Surgical outcomes of patients with primary aldosteronism lateralized with I-131-6 β-iodomethyl-norcholesterol single photon emission/computed tomography without discontinuation or modification of antihypertensive medications.

Authors:  Chia-Hui Chang; Stephen Shei-Dei Yang; Yao-Chou Tsai; Shi-Wen Kuo; Shiou-Chi Cherng; Ching-Chu Lu; Ruoh-Fang Yen; Vin-Cent Wu; Ya-Hui Hu
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2018 Jul-Sep

9.  Feasibility of Iodine-131 6β-Methyl-Iodo-19 Norcholesterol (NP-59) Scintigraphy to Complement Adrenal Venous Sampling in Management of Primary Aldosteronism: A Case Series.

Authors:  Jeongmin Lee; Jeonghoon Ha; Sang-Kuon Lee; Hye Lim Park; Sung-Hoon Kim; Dong-Jun Lim; Jung Min Lee; Sang-Ah Chang; Moo Il Kang; Min-Hee Kim
Journal:  Int J Gen Med       Date:  2021-03-01

10.  Nuclear medicine imaging in the evaluation of endocrine hypertension.

Authors:  Punit Sharma; Rakesh Kumar
Journal:  Indian J Endocrinol Metab       Date:  2012-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.